Market Size of China Computed Tomography Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 1.34 Billion |
Market Size (2029) | USD 1.79 Billion |
CAGR (2024 - 2029) | 5.98 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
China Computed Tomography Market Analysis
The China Computed Tomography Market size is estimated at USD 1.34 billion in 2024, and is expected to reach USD 1.79 billion by 2029, growing at a CAGR of 5.98% during the forecast period (2024-2029).
Factors such as the growing burden of chronic diseases and technological advancements in computed tomography are expected to drive the market during the forecast period. For instance, according to a study published in the Chinese Medical Journal in March 2022, there were around 4,820,000 cancer cases and 3,210,000 cancer deaths in China in 2022. In China, lung cancer is the most frequent type of cancer. Thus, the growing burden of cancer is expected to boost the demand for effective diagnosis devices, which is likely to contribute to market growth.
China offers many opportunities to key players in the market. Therefore, many foreign players are trying to establish their presence in the Chinese market. For instance, in February 2022, Siemens Healthineers and Universal Medical Imaging agreed to promote 5G remote imaging diagnosis for primary care in China.
Various strategic initiatives are being undertaken by the major players. These include mergers, acquisitions, collaborations, partnerships, and product launches. Similarly, the introduction of AI-powered technologies in CT scanning is expected to boost market growth. For instance, in May 2023, Royal Philips, the parent company of Philips Healthcare, introduced a cutting-edge 32/64-slice CT scanner powered by artificial intelligence (AI). This innovative scanner is designed to bolster both routine radiology studies and large-scale screening programs.
Hence, owing to these factors, the market is expected to witness significant growth in the country. However, the high cost associated with the CT scan and procedures may hamper market growth over the forecast period.
China Computed Tomography Industry Segmentation
As per the scope of the report, computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body.
China's computed tomography (CT) market is segmented by type, application, and end user. By type, the market is segmented into low slice, medium slice, and high slice. By application, the market is segmented into oncology, neurology, cardiovascular, musculoskeletal, and other applications. By end user, the market is segmented into hospitals, diagnostic centers, and other end users. The report offers the value (USD) for all the above segments.
By Type | |
Low Slice | |
Medium Slice | |
High Slice |
By Application | |
Oncology | |
Neurology | |
Cardiovascular | |
Musculoskeletal | |
Other Applications |
By End User | |
Hospitals | |
Diagnostic Centers | |
Other End Users |
China Computed Tomography Market Size Summary
The China computed tomography market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and advancements in imaging technology. The demand for effective diagnostic devices is expected to rise, particularly due to the high incidence of cancer, with lung cancer being the most common. This demand is further bolstered by strategic initiatives from key players, including foreign companies seeking to establish a foothold in the Chinese market. Collaborations and partnerships, such as those between Siemens Healthineers and Universal Medical Imaging, are enhancing the capabilities of CT imaging through innovations like 5G remote imaging diagnosis. The introduction of AI-powered technologies, exemplified by Royal Philips' advanced CT scanner, is also anticipated to contribute significantly to market expansion.
Hospitals remain the primary end users of computed tomography, with their share expected to grow due to the high frequency of dental, cardiovascular, and orthopedic diseases, alongside cancer. The segment's growth is supported by increased awareness of CT imaging services and substantial investments in healthcare infrastructure. Strategic collaborations, such as GE Healthcare's joint venture with Sinopharm, aim to develop and commercialize medical equipment tailored to China's healthcare needs. The rising burden of neurological disorders, particularly among the aging population, further propels the demand for CT scans. Major players like Canon Medical Systems, Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers dominate the market, focusing on technological advancements to maintain their competitive edge.
China Computed Tomography Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Geriatric Population and Chronic Disease Burden
-
1.2.2 Technological Advancements in Computed Tomography
-
-
1.3 Market Restraints
-
1.3.1 High Cost Associated With CT Scan Procedure and Equipment
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Type
-
2.1.1 Low Slice
-
2.1.2 Medium Slice
-
2.1.3 High Slice
-
-
2.2 By Application
-
2.2.1 Oncology
-
2.2.2 Neurology
-
2.2.3 Cardiovascular
-
2.2.4 Musculoskeletal
-
2.2.5 Other Applications
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Diagnostic Centers
-
2.3.3 Other End Users
-
-
China Computed Tomography Market Size FAQs
How big is the China Computed Tomography Market?
The China Computed Tomography Market size is expected to reach USD 1.34 billion in 2024 and grow at a CAGR of 5.98% to reach USD 1.79 billion by 2029.
What is the current China Computed Tomography Market size?
In 2024, the China Computed Tomography Market size is expected to reach USD 1.34 billion.